vimarsana.com
Home
Live Updates
Windtree Presents Data from its Positive SEISMiC Phase 2 Stu
Windtree Presents Data from its Positive SEISMiC Phase 2 Stu
Windtree Presents Data from its Positive SEISMiC Phase 2 Study of Istaroxime in Early Cardiogenic Shock in a Late-Breaker Presentation at the European Society of Cardiology Heart Failure Meeting in Madrid
The study met its primary endpoint of improved systolic blood pressure profile at 6 hours with the istaroxime group performing significantly better than the control group Increased SBP also persisted... | May 23, 2022
Related Keywords
Italy ,
United States ,
Russia ,
Spain ,
Ukraine ,
Madrid ,
Robert Flamm ,
Monique Kosse ,
Steven Simonson ,
Marco Metra ,
Craig Fraser ,
Burns Mcclellan Inc ,
Windtree Therapeutics Inc ,
Society For Cardiovascular Angiography Interventions ,
Exchange Commission ,
Institute Of Cardiology ,
European Society Of Cardiology Heart Failure Meeting ,
Globenewswire Inc ,
Cardiology Heart Failure Meeting ,
Cardiovascular Angiography ,
Chief Medical Officer ,
Private Securities Litigation Reform Act ,
Windtree Therapeutics ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
The ,
Study ,
Pet ,
Its ,
Primary ,
Ndpoint ,
F ,
Mproved ,
Wsystolic ,
Flood ,
Pressure ,
Profile ,
It ,
,
Tours ,
Ith ,
Istaroxime ,
Group ,
Performing ,
Ignificantly ,
Setter ,
Han ,
Control ,
Ncreased ,
Bp ,
Lso Wint Us97382d3035 ,